However, no increase in tumor PD-L1 expression and T-cell infiltrates (CD8+, CD4+, and FOXP3+ cells) was observed in the on-study biopsy of patients derived from the CRC cohort [81]. The gene discussed is CD4; the disease is neoplasm.